 Marsha Guess
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 13 | 2024 | 59 | 3.290 |
Why?
| | Urinary Incontinence | 4 | 2019 | 66 | 1.460 |
Why?
| | Pelvic Floor | 4 | 2021 | 28 | 1.310 |
Why?
| | Bicycling | 4 | 2014 | 117 | 1.300 |
Why?
| | Genitalia, Female | 6 | 2017 | 41 | 1.170 |
Why?
| | Sexual Dysfunction, Physiological | 5 | 2017 | 66 | 1.110 |
Why?
| | Postpartum Period | 2 | 2019 | 343 | 0.890 |
Why?
| | Pelvic Floor Disorders | 3 | 2022 | 16 | 0.830 |
Why?
| | Ligaments | 7 | 2024 | 74 | 0.760 |
Why?
| | Vibration | 4 | 2017 | 72 | 0.680 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2019 | 1395 | 0.580 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2019 | 60 | 0.580 |
Why?
| | Constipation | 1 | 2019 | 96 | 0.570 |
Why?
| | Physical Examination | 1 | 2019 | 242 | 0.560 |
Why?
| | Uterus | 6 | 2024 | 220 | 0.530 |
Why?
| | Vagina | 5 | 2016 | 188 | 0.520 |
Why?
| | Electric Stimulation Therapy | 1 | 2017 | 81 | 0.500 |
Why?
| | Puerperal Disorders | 1 | 2013 | 33 | 0.400 |
Why?
| | Fecal Incontinence | 3 | 2022 | 90 | 0.370 |
Why?
| | Body Mass Index | 3 | 2015 | 2374 | 0.360 |
Why?
| | Sensation | 3 | 2012 | 56 | 0.350 |
Why?
| | Surgery, Plastic | 1 | 2012 | 48 | 0.350 |
Why?
| | Sacrum | 4 | 2020 | 71 | 0.310 |
Why?
| | Pregnancy | 4 | 2019 | 7035 | 0.300 |
Why?
| | Recovery of Function | 1 | 2013 | 680 | 0.300 |
Why?
| | Female | 33 | 2025 | 75540 | 0.270 |
Why?
| | Clitoris | 2 | 2006 | 9 | 0.270 |
Why?
| | Adult | 18 | 2024 | 39134 | 0.260 |
Why?
| | Cross-Sectional Studies | 6 | 2019 | 5645 | 0.250 |
Why?
| | Young Adult | 7 | 2024 | 13646 | 0.240 |
Why?
| | Homeodomain Proteins | 4 | 2012 | 512 | 0.240 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.230 |
Why?
| | Gentamicins | 1 | 2025 | 51 | 0.220 |
Why?
| | Hysterectomy | 4 | 2024 | 137 | 0.220 |
Why?
| | Sexual Behavior | 3 | 2017 | 493 | 0.220 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2024 | 66 | 0.210 |
Why?
| | Running | 1 | 2006 | 232 | 0.210 |
Why?
| | Consensus | 3 | 2022 | 545 | 0.200 |
Why?
| | Humans | 34 | 2025 | 140898 | 0.200 |
Why?
| | Mast Cells | 1 | 2024 | 153 | 0.190 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 229 | 0.190 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 193 | 0.190 |
Why?
| | Middle Aged | 15 | 2024 | 34487 | 0.190 |
Why?
| | Perineum | 2 | 2012 | 38 | 0.180 |
Why?
| | Suburethral Slings | 2 | 2013 | 8 | 0.180 |
Why?
| | Pelvis | 2 | 2016 | 115 | 0.180 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 360 | 0.180 |
Why?
| | Delivery, Obstetric | 3 | 2015 | 162 | 0.170 |
Why?
| | Equipment Design | 2 | 2014 | 525 | 0.170 |
Why?
| | Uterine Prolapse | 4 | 2009 | 15 | 0.170 |
Why?
| | Cesarean Section | 3 | 2013 | 213 | 0.170 |
Why?
| | Pain Management | 1 | 2024 | 395 | 0.170 |
Why?
| | Receptors, Estrogen | 1 | 2023 | 411 | 0.170 |
Why?
| | Sexual Dysfunctions, Psychological | 3 | 2012 | 30 | 0.160 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 5931 | 0.150 |
Why?
| | Pelvic Pain | 1 | 2019 | 41 | 0.150 |
Why?
| | Radiology | 1 | 2021 | 170 | 0.140 |
Why?
| | Orgasm | 1 | 2017 | 6 | 0.140 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.130 |
Why?
| | Models, Animal | 2 | 2016 | 393 | 0.130 |
Why?
| | Logistic Models | 2 | 2019 | 2088 | 0.120 |
Why?
| | Prospective Studies | 4 | 2020 | 7749 | 0.120 |
Why?
| | Connecticut | 1 | 2015 | 24 | 0.120 |
Why?
| | Surgical Mesh | 2 | 2013 | 52 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1856 | 0.110 |
Why?
| | Risk Factors | 4 | 2020 | 10430 | 0.110 |
Why?
| | Consumer Product Safety | 1 | 2013 | 30 | 0.100 |
Why?
| | Urinary Incontinence, Stress | 1 | 2013 | 15 | 0.100 |
Why?
| | Trial of Labor | 1 | 2013 | 18 | 0.100 |
Why?
| | Women's Health | 2 | 2006 | 308 | 0.100 |
Why?
| | Libido | 1 | 2012 | 24 | 0.100 |
Why?
| | China | 1 | 2013 | 220 | 0.100 |
Why?
| | Aged | 7 | 2024 | 24666 | 0.090 |
Why?
| | Adolescent | 3 | 2024 | 22027 | 0.090 |
Why?
| | Ovariectomy | 1 | 2012 | 158 | 0.090 |
Why?
| | Endometrial Neoplasms | 1 | 2013 | 196 | 0.080 |
Why?
| | Pressure | 1 | 2011 | 228 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7899 | 0.080 |
Why?
| | Birth Weight | 1 | 2013 | 511 | 0.080 |
Why?
| | Rectovaginal Fistula | 1 | 2009 | 11 | 0.080 |
Why?
| | Rectal Diseases | 1 | 2009 | 24 | 0.080 |
Why?
| | Biopsy | 1 | 2013 | 1069 | 0.080 |
Why?
| | Health Care Costs | 1 | 2013 | 418 | 0.080 |
Why?
| | Pregnancy, Ectopic | 1 | 2009 | 54 | 0.070 |
Why?
| | Abscess | 1 | 2009 | 77 | 0.070 |
Why?
| | Cicatrix | 1 | 2009 | 67 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 430 | 0.070 |
Why?
| | Smoking | 1 | 2013 | 1573 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 803 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2009 | 526 | 0.060 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 31 | 0.060 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2024 | 16 | 0.060 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2004 | 28 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2005 | 143 | 0.050 |
Why?
| | Age Factors | 1 | 2012 | 3278 | 0.050 |
Why?
| | Urologic Surgical Procedures | 1 | 2005 | 118 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5194 | 0.050 |
Why?
| | Fibroblasts | 1 | 2009 | 1017 | 0.050 |
Why?
| | Ultrasonography | 2 | 2021 | 760 | 0.050 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 41 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1496 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 357 | 0.050 |
Why?
| | Receptors, Androgen | 1 | 2023 | 153 | 0.050 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 144 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 5789 | 0.050 |
Why?
| | Public Opinion | 1 | 2022 | 60 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 552 | 0.050 |
Why?
| | Menopause | 1 | 2005 | 317 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2013 | 6257 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2009 | 2497 | 0.040 |
Why?
| | Mice | 5 | 2025 | 18057 | 0.040 |
Why?
| | Radiography, Abdominal | 1 | 2021 | 44 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 367 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2012 | 2813 | 0.040 |
Why?
| | Child | 1 | 2019 | 22313 | 0.040 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 149 | 0.040 |
Why?
| | Neutrophils | 1 | 2024 | 1282 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3578 | 0.040 |
Why?
| | Research Design | 1 | 2004 | 1104 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 813 | 0.030 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 5895 | 0.030 |
Why?
| | Macrophages | 1 | 2024 | 1559 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 39 | 0.030 |
Why?
| | Animals | 5 | 2025 | 37579 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1114 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2016 | 154 | 0.030 |
Why?
| | Sensory Thresholds | 2 | 2005 | 31 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4597 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 16315 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1917 | 0.030 |
Why?
| | Device Approval | 1 | 2013 | 17 | 0.030 |
Why?
| | Decision Trees | 1 | 2013 | 81 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2891 | 0.020 |
Why?
| | Gelatinases | 1 | 2012 | 7 | 0.020 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2012 | 12 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2898 | 0.020 |
Why?
| | Collagen Type III | 1 | 2012 | 18 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 2012 | 15 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 28 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3172 | 0.020 |
Why?
| | Nervous System Diseases | 2 | 2005 | 277 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 140 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 562 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 331 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2522 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 609 | 0.020 |
Why?
| | United States | 2 | 2021 | 15195 | 0.020 |
Why?
| | Rectocele | 1 | 2009 | 4 | 0.020 |
Why?
| | Ischium | 1 | 2009 | 6 | 0.020 |
Why?
| | Uterine Artery Embolization | 1 | 2009 | 8 | 0.020 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2009 | 20 | 0.020 |
Why?
| | Pilot Projects | 2 | 2005 | 1815 | 0.020 |
Why?
| | Uterine Hemorrhage | 1 | 2009 | 38 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 2009 | 78 | 0.020 |
Why?
| | Societies, Medical | 1 | 2013 | 852 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3724 | 0.020 |
Why?
| | Prolapse | 1 | 2008 | 6 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1968 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2008 | 57 | 0.020 |
Why?
| | Self Report | 1 | 2012 | 858 | 0.020 |
Why?
| | Methotrexate | 1 | 2009 | 255 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 133 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5594 | 0.020 |
Why?
| | Polypropylenes | 1 | 2005 | 12 | 0.020 |
Why?
| | Anus Diseases | 1 | 2005 | 8 | 0.010 |
Why?
| | Collagen | 1 | 2008 | 460 | 0.010 |
Why?
| | Touch | 1 | 2005 | 36 | 0.010 |
Why?
| | Nervous System | 1 | 2005 | 68 | 0.010 |
Why?
| | Anal Canal | 1 | 2005 | 101 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1328 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1726 | 0.010 |
Why?
| | International Cooperation | 1 | 2004 | 195 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4199 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2004 | 712 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2008 | 2822 | 0.010 |
Why?
| | Comorbidity | 1 | 2005 | 1658 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1536 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 1072 | 0.010 |
Why?
| | Male | 1 | 2013 | 69893 | 0.000 |
Why?
|
|
Guess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|